speb/financial-data huggingface dataset:
Financial ratios for ASTH — annual report dated 2023-12-31
Total revenue: 1386661000
Gross profit: 214958000
Operating income: 84613000
Net income: 60717000
Capital expenditures: 28529000
Operating cash flow: 68227000
Depreciation & amortization: 17748000
Net tangible assets: 263739000
Owner earnings: 49936000
Return on net tangible assets (%): 18.93387022776305
Capex to operating income (%): 33.71704111661329
Buffett classification: The Good
Stock price: 38.3
P/E ratio: 31.276988477691585
Shares outstanding: 49583418
Book value: 410768000
P/B ratio: 4.623156890020645
Market cap (USD): 1899044909.3999999
Debt to equity: 0.7814970981186461
Current ratio: 2.110479526601242
Quick ratio: 2.110479526601242
Effective tax rate (%): 35.607426701395845
Interest coverage ratio: 5.254813066699789
COGS to revenue (%): 84.4981578049718
SG&A to revenue (%): 8.120009144268138
Free cash flow (dilution-adjusted): 17658000
Buyback yield (%): 0.5366908359855558
Retained earnings: 243134000
Receivables turnover: 9.38505739347014
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.839168754993445
FCF margin (%): 1.2734186654128155
Revenue growth (%): 21.19435779692229
Rule of 40 score: 22.467776462335106
Financial ratios for ASTH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 57.94
Shares outstanding: 49583418
Market cap (USD): 2872863238.92
Buyback yield (%): 0.024957679512427573
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASTH — annual report dated 2024-12-31
Total revenue: 2034540000
Gross profit: 271388000
Operating income: 89350000
Net income: 49932000
Capital expenditures: 8031000
Operating cash flow: 52198000
Depreciation & amortization: 27927000
Net tangible assets: 175288000
Owner earnings: 69828000
Return on net tangible assets (%): 39.83615535575738
Capex to operating income (%): 8.988248461108002
Buffett classification: The Great
Stock price: 31.53
P/E ratio: 31.309884834174476
Shares outstanding: 49583418
Book value: 514168000
P/B ratio: 3.0405726718504456
Market cap (USD): 1563365169.54
Debt to equity: 0.9154167509452164
Current ratio: 1.7463950460602613
Quick ratio: 1.7463950460602613
Effective tax rate (%): 38.21673389591428
Interest coverage ratio: 2.6996404507961445
COGS to revenue (%): 86.66096513216746
SG&A to revenue (%): 7.574734337983033
Free cash flow (dilution-adjusted): 9631000
Buyback yield (%): 0.05993481358393702
Retained earnings: 286283000
Receivables turnover: 6.263939261457749
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.031766344616218
FCF margin (%): 0.4733748169119309
Revenue growth (%): 46.72223420143784
Rule of 40 score: 47.19560901834977
Financial ratios for ASTH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.53
Shares outstanding: 49583418
Market cap (USD): 1563365169.54
Buyback yield (%): 0.014072208098683186
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASTH — quarterly report dated 2025-03-31
Total revenue: 620390000
Gross profit: 71329000
Operating income: 20583000
Net income: 6692000
Capital expenditures: 3070000
Operating cash flow: 16627000
Depreciation & amortization: 6849000
Net tangible assets: 217066000
Owner earnings: 10471000
Return on net tangible assets (%): 4.823878451715147
Capex to operating income (%): 14.91522129913035
Buffett classification: The Great
Stock price: 31.01
P/E ratio: 57.441041250000005
Shares outstanding: 49583418
Book value: 517706000
P/B ratio: 2.9699902882717217
Market cap (USD): 1537581792.18
Debt to equity: 0.8718268669862818
Current ratio: 1.6975486342549022
Quick ratio: 1.6975486342549022
Effective tax rate (%): 35.22490628904623
Interest coverage ratio: 2.8165024630541873
COGS to revenue (%): 88.50255484453328
SG&A to revenue (%): 7.075710440206967
Free cash flow (dilution-adjusted): 5746000
Buyback yield (%): 0
Retained earnings: 292880000
Receivables turnover: 1.8877207929528823
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1219850142475987
FCF margin (%): 0.9261915891616564
Rule of 40 score: 0.9261915891616564
Financial ratios for ASTH — quarterly report dated 2025-06-30
Total revenue: 654808000
Gross profit: 77969000
Operating income: 20340000
Net income: 10216000
Capital expenditures: 1420000
Operating cash flow: 90900000
Depreciation & amortization: 6904000
Net tangible assets: 242807000
Owner earnings: 15700000
Return on net tangible assets (%): 6.466040929627234
Capex to operating income (%): 6.981317600786626
Buffett classification: The Great
Stock price: 24.88
P/E ratio: 72.9616418168914
Shares outstanding: 49583418
Book value: 537946000
P/B ratio: 2.2932328520706537
Market cap (USD): 1233635439.84
Debt to equity: 0.8320351856877828
Current ratio: 1.585988785111779
Quick ratio: 1.585988785111779
Effective tax rate (%): 39.280832095096585
Interest coverage ratio: 2.7553508534272555
COGS to revenue (%): 88.092998252923
SG&A to revenue (%): 7.7465455522840285
Free cash flow (dilution-adjusted): 77772000
Buyback yield (%): 0
Retained earnings: 302209000
Receivables turnover: 1.7926291755868133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.07000989208267
FCF margin (%): 11.87706930886611
Revenue growth (%): 5.547800577056368
Rule of 40 score: 17.424869885922476
Financial ratios for ASTH — quarterly report dated 2025-09-30
Total revenue: 956048000
Gross profit: 97192000
Operating income: 19210000
Net income: 1077000
Capital expenditures: 2552000
Operating cash flow: 9956000
Depreciation & amortization: 15596000
Net tangible assets: -372783000
Owner earnings: 14121000
Return on net tangible assets (%): -3.787994624218379
Capex to operating income (%): 13.284747527329516
Buffett classification: The Great
Stock price: 28.35
P/E ratio: 78.15901586321935
Shares outstanding: 49583418
Book value: 554724000
P/B ratio: 2.5340347637744176
Market cap (USD): 1405689900.3
Debt to equity: 1.9599710847196083
Current ratio: 1.4027415744606544
Quick ratio: 1.4027415744606544
Effective tax rate (%): 81.0086404514195
Interest coverage ratio: 1.0842081499040523
COGS to revenue (%): 89.83398323096749
SG&A to revenue (%): 6.525509179455424
Free cash flow (dilution-adjusted): -296000
Buyback yield (%): 0
Retained earnings: 302486000
Receivables turnover: 2.4080661127049336
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.195204746474737
FCF margin (%): -0.030960788579652905
Revenue growth (%): 46.004324931888426
Rule of 40 score: 45.97336414330877
Financial ratios for ASTH — quarterly report dated 2025-12-31
Total revenue: 950526000
Gross profit: 95043000
Operating income: 18395000
Net income: 6562000
Capital expenditures: 3064000
Operating cash flow: -2886000
Depreciation & amortization: 16401000
Net tangible assets: -356982000
Owner earnings: 19899000
Return on net tangible assets (%): -5.574230633477318
Capex to operating income (%): 16.656700190269095
Buffett classification: The Great
Stock price: 24.81
P/E ratio: 50.11466169307858
Shares outstanding: 49583418
Book value: 558334000
P/B ratio: 2.2032772508570138
Market cap (USD): 1230164600.58
Debt to equity: 1.930976798833673
Current ratio: 1.4031381191763657
Quick ratio: 1.4031381191763657
Effective tax rate (%): 12.576605382360778
Interest coverage ratio: 1.0499429223744292
COGS to revenue (%): 90.00100996711295
SG&A to revenue (%): 6.338280068088616
Free cash flow (dilution-adjusted): -17332000
Buyback yield (%): 0
Retained earnings: 308379000
Receivables turnover: 2.332149911059314
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1472581808021516
FCF margin (%): -1.823411458497716
Revenue growth (%): -0.5775860626244707
Rule of 40 score: -2.4009975211221866
Financial ratios for ASTH — annual report dated 2025-12-31
Total revenue: 3181769000
Gross profit: 341530000
Operating income: 78525000
Net income: 24076000
Capital expenditures: 10106000
Operating cash flow: 114597000
Depreciation & amortization: 45749000
Net tangible assets: -356982000
Owner earnings: 59719000
Return on net tangible assets (%): -16.728854676146135
Capex to operating income (%): 12.869786692136262
Buffett classification: The Great
Stock price: 24.81
P/E ratio: 51.09505734258182
Shares outstanding: 49583418
Book value: 558334000
P/B ratio: 2.2032772508570138
Market cap (USD): 1230164600.58
Debt to equity: 1.930976798833673
Current ratio: 1.4031381191763657
Quick ratio: 1.4031381191763657
Effective tax rate (%): 39.21123062162299
Interest coverage ratio: 1.5727647812850505
COGS to revenue (%): 89.2660340835554
SG&A to revenue (%): 6.828151257995159
Free cash flow (dilution-adjusted): 65890000
Buyback yield (%): 1.2542224018416326
Retained earnings: 308379000
Receivables turnover: 7.806585291050727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.897442166213044
FCF margin (%): 2.0708605810164094
Revenue growth (%): 56.38763553432226
Rule of 40 score: 58.45849611533867
Financial ratios for AZE.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.795454545454543
Shares outstanding: 243379497
Market cap (USD): 6521464249.15909
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZE.BR — annual report dated 2022-12-31
Total revenue: 4388189361.702127
Gross profit: 1022067021.2765958
Operating income: 413221276.5957447
Net income: 232850000
Capital expenditures: 19620212.76595745
Operating cash flow: 392781914.89361703
Depreciation & amortization: 90140425.5319149
Net tangible assets: -1021501063.8297873
Owner earnings: 303370212.7659574
Return on net tangible assets (%): -29.69847252322666
Capex to operating income (%): 4.74811290638162
Buffett classification: The Great
Stock price: 26.414893617021278
P/E ratio: 27.609377375216443
Shares outstanding: 243379497
Book value: 2595401063.8297877
P/B ratio: 2.477013518801874
Market cap (USD): 6428843521.819149
Debt to equity: 0.5884742119551071
Current ratio: 1.4810338905720541
Quick ratio: 0.8374298325208004
Effective tax rate (%): 30.441732608764738
Interest coverage ratio: 10.163483175467059
COGS to revenue (%): 76.7086846753544
SG&A to revenue (%): 3.84872547151469
Free cash flow (dilution-adjusted): 372269148.9361703
Buyback yield (%): 0.04962674112516134
Retained earnings: 431662765.9574468
Inventory turnover: 5.0405823467190025
Receivables turnover: 9.305232715525797
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.707350963917447
FCF margin (%): 8.483434014610786
Rule of 40 score: 8.483434014610786
Financial ratios for AZE.BR — annual report dated 2023-12-31
Total revenue: 4639636666.666667
Gross profit: 1093466666.6666667
Operating income: 429891111.1111111
Net income: 210346666.66666666
Capital expenditures: 17205555.555555556
Operating cash flow: 583442222.2222222
Depreciation & amortization: 112332222.22222222
Net tangible assets: -1298207777.7777777
Owner earnings: 305473333.3333333
Return on net tangible assets (%): -23.53038847573621
Capex to operating income (%): 4.002305493380753
Buffett classification: The Great
Stock price: 23.377777777777776
P/E ratio: 27.04902286637931
Shares outstanding: 243379497
Book value: 2973975555.555556
P/B ratio: 1.913153517992003
Market cap (USD): 5689671796.533333
Debt to equity: 0.6635704246242776
Current ratio: 1.6956516187249402
Quick ratio: 1.0967797887102126
Effective tax rate (%): 23.429246313268994
Interest coverage ratio: 3.9736461018620273
COGS to revenue (%): 76.43206256811776
SG&A to revenue (%): 3.9938472193584125
Free cash flow (dilution-adjusted): 564711111.111111
Buyback yield (%): 0.06655334089698899
Retained earnings: 707862222.2222222
Inventory turnover: 5.670938234619956
Receivables turnover: 9.38642458464741
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.35194828856102
FCF margin (%): 12.171451164878091
Revenue growth (%): 5.730092396628163
Rule of 40 score: 17.901543561506255
Financial ratios for AZE.BR — annual report dated 2024-12-31
Total revenue: 4414553125
Gross profit: 1074007291.6666667
Operating income: 402007291.6666667
Net income: 197362500
Capital expenditures: 14455208.333333334
Operating cash flow: 336394791.6666667
Depreciation & amortization: 119710416.66666667
Net tangible assets: -1096340625
Owner earnings: 302617708.3333334
Return on net tangible assets (%): -27.60252620697453
Capex to operating income (%): 3.595757746931415
Buffett classification: The Great
Stock price: 19.020833333333336
P/E ratio: 23.4557266410159
Shares outstanding: 243379497
Book value: 3041818750
P/B ratio: 1.5218792537153967
Market cap (USD): 4629280849.187501
Debt to equity: 0.631471851064981
Current ratio: 1.9330251052054408
Quick ratio: 1.1051260633504056
Effective tax rate (%): 26.02027269745576
Interest coverage ratio: 3.641645278176191
COGS to revenue (%): 75.67121153023464
SG&A to revenue (%): 4.128579454649406
Free cash flow (dilution-adjusted): 320608333.3333334
Buyback yield (%): 0.056411749868053015
Retained earnings: 912839583.3333334
Inventory turnover: 4.730360132459123
Receivables turnover: 8.537772548798397
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.805957355229748
FCF margin (%): 7.262531999393107
Revenue growth (%): -4.851318278514632
Rule of 40 score: 2.411213720878475
Financial ratios for AZE.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -1096340625
Buffett classification: The Gruesome
Stock price: 19.020833333333336
Shares outstanding: 243379497
Book value: 3041818750
P/B ratio: 1.5218792537153967
Market cap (USD): 4629280849.187501
Debt to equity: 0.631471851064981
Current ratio: 1.9330251052054408
Quick ratio: 1.1051260633504056
Buyback yield (%): 0
Retained earnings: 912839583.3333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZE.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -1234247058.8235295
Buffett classification: The Gruesome
Stock price: 15.55294117647059
Shares outstanding: 243379497
Book value: 3148022352.9411764
P/B ratio: 1.2024269766901274
Market cap (USD): 3785267000.4000006
Debt to equity: 0.7722435635594186
Current ratio: 1.6756258009065434
Quick ratio: 1.049752946461038
Buyback yield (%): 0
Retained earnings: 1131951764.7058823
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBW — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.82
Shares outstanding: 12537443
Market cap (USD): 198342348.26
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBW — annual report dated 2023-01-31
Total revenue: 467937000
Gross profit: 245872000
Operating income: 61943000
Net income: 47985000
Capital expenditures: 13634000
Operating cash flow: 47276000
Depreciation & amortization: 12482000
Net tangible assets: 119117000
Owner earnings: 46833000
Return on net tangible assets (%): 39.31680616536683
Capex to operating income (%): 22.010558093731333
Buffett classification: The Great
Stock price: 21.77
P/E ratio: 5.688030303428154
Shares outstanding: 12537443
Book value: 119117000
P/B ratio: 2.2913617209130517
Market cap (USD): 272940134.11
Debt to equity: 0.7263111058874888
Current ratio: 1.4575337861217388
Quick ratio: 0.760704293580884
Effective tax rate (%): 22.50985078483302
COGS to revenue (%): 47.45617465599001
SG&A to revenue (%): 39.30635961678602
Free cash flow (dilution-adjusted): 31083000
Buyback yield (%): 8.85615451125199
Retained earnings: 61375000
Inventory turnover: 3.1505284812371426
Receivables turnover: 30.436906465461167
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.48116542253247
FCF margin (%): 6.642560857551337
Rule of 40 score: 6.642560857551337
Financial ratios for BBW — annual report dated 2024-01-31
Total revenue: 486114000
Gross profit: 264392000
Operating income: 65400000
Net income: 52805000
Capital expenditures: 18295000
Operating cash flow: 64310000
Depreciation & amortization: 13657000
Net tangible assets: 129662000
Owner earnings: 48167000
Return on net tangible assets (%): 37.148123582853884
Capex to operating income (%): 27.97400611620795
Buffett classification: The Good
Stock price: 21.29
P/E ratio: 5.054865286809961
Shares outstanding: 12537443
Book value: 129662000
P/B ratio: 2.0585997552868225
Market cap (USD): 266922161.47
Debt to equity: 0.6445219108142709
Current ratio: 1.5259455650699247
Quick ratio: 0.767594616220606
Effective tax rate (%): 20.389271660962777
COGS to revenue (%): 45.611111796821326
SG&A to revenue (%): 40.93525387049128
Free cash flow (dilution-adjusted): 43926000
Buyback yield (%): 7.680141613982862
Retained earnings: 75272000
Inventory turnover: 3.4917400274020065
Receivables turnover: 56.72937332244136
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.678035123441084
FCF margin (%): 9.036152013725175
Revenue growth (%): 3.8844972720686757
Rule of 40 score: 12.92064928579385
Financial ratios for BBW — quarterly report dated 2024-10-31
Capital expenditures: 3871000
Buffett classification: The Gruesome
Stock price: 36.76
Shares outstanding: 12537443
Market cap (USD): 460876404.67999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBW — quarterly report dated 2025-01-31
Total revenue: 150446000
Gross profit: 85144000
Operating income: 27348000
Net income: 21678000
Capital expenditures: 9746000
Operating cash flow: 19511000
Depreciation & amortization: 3789000
Net tangible assets: 139082000
Owner earnings: 15721000
Return on net tangible assets (%): 11.303403747429574
Capex to operating income (%): 35.63697528155624
Buffett classification: The Good
Stock price: 41.08
P/E ratio: 5.939641092812989
Shares outstanding: 12537443
Book value: 139082000
P/B ratio: 3.7031259144964843
Market cap (USD): 515038158.44
Debt to equity: 0.6974015329086438
Current ratio: 1.5907751215457087
Quick ratio: 0.7119303725722347
Effective tax rate (%): 21.130757476533507
COGS to revenue (%): 43.4056073275461
SG&A to revenue (%): 38.4164417797748
Free cash flow (dilution-adjusted): 9284000
Buyback yield (%): 1.5697866007615184
Retained earnings: 89516000
Inventory turnover: 0.9358939448226442
Receivables turnover: 9.346794234592446
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.988098517301317
FCF margin (%): 6.170984938117331
Rule of 40 score: 6.170984938117331
Financial ratios for BBW — annual report dated 2025-01-31
Total revenue: 496404000
Gross profit: 272518000
Operating income: 66280000
Net income: 51785000
Capital expenditures: 19317000
Operating cash flow: 47087000
Depreciation & amortization: 14772000
Net tangible assets: 139082000
Owner earnings: 47240000
Return on net tangible assets (%): 33.96557426554119
Capex to operating income (%): 29.14453832226916
Buffett classification: The Good
Stock price: 41.08
P/E ratio: 9.945701620932702
Shares outstanding: 12537443
Book value: 139082000
P/B ratio: 3.7031259144964843
Market cap (USD): 515038158.44
Debt to equity: 0.6974015329086438
Current ratio: 1.5907751215457087
Quick ratio: 0.7119303725722347
Effective tax rate (%): 22.871270907493184
COGS to revenue (%): 45.10157049500004
SG&A to revenue (%): 41.54640172117872
Free cash flow (dilution-adjusted): 25595000
Buyback yield (%): 6.0706181644291455
Retained earnings: 89516000
Inventory turnover: 3.2086850591185954
Receivables turnover: 30.84020874751491
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.477664535861173
FCF margin (%): 5.156082545668447
Revenue growth (%): 2.11678742023476
Rule of 40 score: 7.272869965903206
Financial ratios for BBW — quarterly report dated 2025-04-30
Total revenue: 128395000
Gross profit: 72986000
Operating income: 19431000
Net income: 15319000
Capital expenditures: 2907000
Operating cash flow: 27803000
Depreciation & amortization: 3700000
Net tangible assets: 148682000
Owner earnings: 16112000
Return on net tangible assets (%): 10.836550490308175
Capex to operating income (%): 14.960629921259844
Buffett classification: The Great
Stock price: 34.43
P/E ratio: 7.044587807461323
Shares outstanding: 12537443
Book value: 148682000
P/B ratio: 2.9032711591853753
Market cap (USD): 431664162.49
Debt to equity: 0.6689713616981208
Current ratio: 1.6707127040104979
Quick ratio: 0.8236341694883481
Effective tax rate (%): 21.96525902908665
COGS to revenue (%): 43.15510728610927
SG&A to revenue (%): 41.71112582265665
Free cash flow (dilution-adjusted): 23350000
Buyback yield (%): 0.9748319100030647
Retained earnings: 98243000
Inventory turnover: 0.7663868103293269
Receivables turnover: 9.303985507246377
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.715328860023682
FCF margin (%): 18.186066435608865
Revenue growth (%): -14.65708626350983
Rule of 40 score: 3.5289801720990344
Financial ratios for BBW — quarterly report dated 2025-07-31
Total revenue: 124247000
Gross profit: 71511000
Operating income: 15112000
Net income: 12367000
Capital expenditures: 3421000
Operating cash flow: 4214000
Depreciation & amortization: 3668000
Net tangible assets: 155395000
Owner earnings: 12614000
Return on net tangible assets (%): 8.117378294024904
Capex to operating income (%): 22.637638962413973
Buffett classification: The Great
Stock price: 49.69
P/E ratio: 12.620240310145045
Shares outstanding: 12537443
Book value: 155395000
P/B ratio: 4.009044967148235
Market cap (USD): 622985542.67
Debt to equity: 0.6908909553074424
Current ratio: 1.7813548450759817
Quick ratio: 0.772893230708506
Effective tax rate (%): 19.264917091004047
COGS to revenue (%): 42.44448558114079
SG&A to revenue (%): 45.39264529525864
Free cash flow (dilution-adjusted): 1167000
Buyback yield (%): 0.5000116032628447
Retained earnings: 104866000
Inventory turnover: 0.6450255632476333
Receivables turnover: 9.185790329735324
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.371908283649427
FCF margin (%): 0.9392580907386094
Revenue growth (%): -3.2306553993535574
Rule of 40 score: -2.2913973086149477
Financial ratios for BBW — quarterly report dated 2025-10-31
Total revenue: 122679000
Gross profit: 65822000
Operating income: 10508000
Net income: 8122000
Capital expenditures: 6543000
Operating cash flow: 8243000
Depreciation & amortization: 3699000
Net tangible assets: 150617000
Owner earnings: 5278000
Return on net tangible assets (%): 3.5042525080170237
Capex to operating income (%): 62.266844309097834
Buffett classification: The Good
Stock price: 53.3
P/E ratio: 11.624494866576208
Shares outstanding: 12537443
Book value: 150617000
P/B ratio: 4.436721697417954
Market cap (USD): 668245711.9
Debt to equity: 0.7848649222863289
Current ratio: 1.6540271309012105
Quick ratio: 0.6569724979346512
Effective tax rate (%): 24.298629881629232
COGS to revenue (%): 46.34615541372199
SG&A to revenue (%): 45.08840143789891
Free cash flow (dilution-adjusted): 670000
Buyback yield (%): 1.5254867810547936
Retained earnings: 100696000
Inventory turnover: 0.6827619333533473
Receivables turnover: 7.8812154696132595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.324671369424393
FCF margin (%): 0.5461407412841643
Revenue growth (%): -1.2620023018664435
Rule of 40 score: -0.7158615605822791
Financial ratios for BBW — quarterly report dated 2026-01-31
Total revenue: 154511000
Gross profit: 85310000
Operating income: 21375000
Net income: 16395000
Capital expenditures: 12674000
Operating cash flow: 24792000
Depreciation & amortization: 3885000
Net tangible assets: 155028000
Owner earnings: 7606000
Return on net tangible assets (%): 4.906210491008077
Capex to operating income (%): 59.29356725146199
Buffett classification: The Good
Stock price: 58.91
P/E ratio: 14.148243724115472
Shares outstanding: 12537443
Book value: 155028000
P/B ratio: 4.764176581843279
Market cap (USD): 738580767.13
Debt to equity: 0.8211290863585933
Current ratio: 1.5450312272416304
Quick ratio: 0.6379736499459316
Effective tax rate (%): 23.91758318251427
COGS to revenue (%): 44.78710253638899
SG&A to revenue (%): 41.3789309499
Free cash flow (dilution-adjusted): 11390000
Buyback yield (%): 1.3834641321226682
Retained earnings: 104839000
Inventory turnover: 0.841830590124448
Receivables turnover: 7.200288923062584
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.388043653145075
FCF margin (%): 7.371643442861673
Revenue growth (%): 25.94739115904107
Rule of 40 score: 33.31903460190274
Financial ratios for BBW — annual report dated 2026-01-31
Total revenue: 529832000
Gross profit: 295629000
Operating income: 66426000
Net income: 52203000
Capital expenditures: 25545000
Operating cash flow: 65052000
Depreciation & amortization: 14952000
Net tangible assets: 155028000
Owner earnings: 41610000
Return on net tangible assets (%): 26.84031271770261
Capex to operating income (%): 38.45632734170355
Buffett classification: The Good
Stock price: 58.91
P/E ratio: 14.148243724115472
Shares outstanding: 12537443
Book value: 155028000
P/B ratio: 4.764176581843279
Market cap (USD): 738580767.13
Debt to equity: 0.8211290863585933
Current ratio: 1.5450312272416304
Quick ratio: 0.6379736499459316
Effective tax rate (%): 22.348163684234013
COGS to revenue (%): 44.20325688142657
SG&A to revenue (%): 43.259561521387916
Free cash flow (dilution-adjusted): 36577000
Buyback yield (%): 3.755174956392856
Retained earnings: 104839000
Inventory turnover: 2.8490809337858716
Receivables turnover: 24.690432918588936
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.067096500763263
FCF margin (%): 6.903509036826767
Revenue growth (%): 6.734031152045511
Rule of 40 score: 13.63754018887228
Financial ratios for BLEE.PA — annual report dated 2021-08-31
Operating income: 25624705.88235294
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 111.11764705882354
Shares outstanding: 1124686
Market cap (USD): 124972462.00000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLEE.PA — annual report dated 2022-08-31
Total revenue: 23915000
Operating income: 2007000
Net income: -5173000
Capital expenditures: 10481000
Operating cash flow: 261000
Net tangible assets: 323608000
Owner earnings: -15654000
Return on net tangible assets (%): -4.837334058490519
Capex to operating income (%): 522.2222222222223
Buffett classification: The Gruesome
Stock price: 161.85
Shares outstanding: 1124686
Book value: 326608000
P/B ratio: 0.5573361004629402
Market cap (USD): 182030429.1
Debt to equity: 1.0348950423749572
Current ratio: 0.11391551314409767
Quick ratio: 0.11391551314409767
Interest coverage ratio: 0.2015262576563912
COGS to revenue (%): 0
SG&A to revenue (%): 68.73928496759356
Free cash flow (dilution-adjusted): -10220000
Buyback yield (%): 0
Retained earnings: -5173000
Receivables turnover: 1.702377562642369
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3610614883936812
FCF margin (%): -42.7346853439264
Rule of 40 score: -42.7346853439264
Financial ratios for BLEE.PA — annual report dated 2023-08-31
Total revenue: 32008791.208791208
Operating income: 11942857.142857142
Net income: -28581318.68131868
Capital expenditures: 726373.6263736263
Operating cash flow: 5703296.703296703
Net tangible assets: 327032967.03296703
Owner earnings: -29307692.307692308
Return on net tangible assets (%): -8.961693548387096
Capex to operating income (%): 6.082075818917923
Buffett classification: The Great
Stock price: 178.79120879120876
Shares outstanding: 1124686
Book value: 330329670.32967037
P/B ratio: 0.608737232867598
Market cap (USD): 201083969.45054942
Debt to equity: 1.231902860944777
Current ratio: 0.49929270305316514
Quick ratio: 0.49929270305316514
Interest coverage ratio: 0.7680565371024735
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 4976923.076923077
Buyback yield (%): 0
Retained earnings: -28581318.68131868
Receivables turnover: 1.657448503471037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6288627037202457
FCF margin (%): 15.54861301840154
Revenue growth (%): 33.843994182693734
Rule of 40 score: 49.392607201095274
Financial ratios for BLEE.PA — annual report dated 2024-08-31
Total revenue: 33286666.666666664
Operating income: 12682222.222222222
Net income: -45931111.11111111
Capital expenditures: 8232222.222222222
Operating cash flow: 8962222.222222222
Net tangible assets: 284734444.4444444
Owner earnings: -54163333.333333336
Return on net tangible assets (%): -19.022402940751814
Capex to operating income (%): 64.91151217802698
Buffett classification: The Good
Stock price: 147.82222222222222
Shares outstanding: 1124686
Book value: 288067777.77777773
P/B ratio: 0.5771335659432002
Market cap (USD): 166253583.82222223
Debt to equity: 1.2082110305830807
Current ratio: 0.8684710953346856
Quick ratio: 0.8684710953346856
Interest coverage ratio: 0.650592795257638
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 730000
Buyback yield (%): 0
Retained earnings: -45931111.11111111
Receivables turnover: 2.0863569886482343
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.035582568251047
FCF margin (%): 2.1930702984177852
Revenue growth (%): 3.9922640300283767
Rule of 40 score: 6.185334328446162
Financial ratios for BLEE.PA — quarterly report dated 2025-02-28
Capital expenditures: 0
Net tangible assets: 264207291.6666667
Buffett classification: The Gruesome
Stock price: 114.75
Shares outstanding: 1124686
Market cap (USD): 129057718.5
Current ratio: 0.9339139160663729
Quick ratio: 0.9339139160663729
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLEE.PA — annual report dated 2025-08-31
Total revenue: 28497674.418604653
Operating income: 8168604.651162791
Net income: -10946511.627906976
Capital expenditures: 9054651.162790697
Operating cash flow: 16587209.302325582
Net tangible assets: 287032558.1395349
Owner earnings: -20001162.79069767
Return on net tangible assets (%): -6.968255768732175
Capex to operating income (%): 110.84697508896797
Buffett classification: The Gruesome
Stock price: 107.40697674418605
Shares outstanding: 1124686
Book value: 290520930.23255813
P/B ratio: 0.4158017907687875
Market cap (USD): 120799123.04651164
Debt to equity: 1.2563158400307388
Current ratio: 0.5567252747252748
Quick ratio: 0.5567252747252748
Interest coverage ratio: 0.49409199606133075
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 7532558.139534884
Buyback yield (%): 0
Retained earnings: -10946511.627906976
Receivables turnover: 1.3456322407071872
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2465022525759568
FCF margin (%): 26.43218540884609
Revenue growth (%): -14.387118710380568
Rule of 40 score: 12.045066698465524
Financial ratios for BLEE.PA — quarterly report dated 2025-08-31
Capital expenditures: 0
Net tangible assets: 287032558.1395349
Buffett classification: The Gruesome
Stock price: 107.40697674418605
Shares outstanding: 1124686
Book value: 290520930.23255813
P/B ratio: 0.4158017907687875
Market cap (USD): 120799123.04651164
Debt to equity: 1.2563158400307388
Current ratio: 0.5567252747252748
Quick ratio: 0.5567252747252748
Buyback yield (%): 0
Retained earnings: -10946511.627906976
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CABP.L — annual report dated 2023-12-31
Total revenue: 173503797.46835443
Net income: 30046835.44303797
Capital expenditures: 534177.2151898734
Operating cash flow: 390843037.9746835
Depreciation & amortization: 7405063.29113924
Net tangible assets: 135741772.15189874
Owner earnings: 36917721.518987335
Return on net tangible assets (%): 27.197023387668313
Buffett classification: The Gruesome
Stock price: 0.01050632911392405
P/E ratio: 0.08876707091881873
Shares outstanding: 253863128
Book value: 166493670.8860762
P/B ratio: 0.016019645422337084
Market cap (USD): 2667169.5726582278
Debt to equity: 0.006720900174865039
Effective tax rate (%): 36.49147991599543
COGS to revenue (%): 0
SG&A to revenue (%): 3.5486036128053224
Free cash flow (dilution-adjusted): 379750632.9113924
Buyback yield (%): 0
Retained earnings: 166427848.10126582
Receivables turnover: 112.81316872427983
Capitalized R&D asset: 0
FCF margin (%): 218.8716549449908
Revenue growth (%): 31.59240818635188
Rule of 40 score: 250.4640631313427
Financial ratios for CABP.L — annual report dated 2024-12-31
Total revenue: 131936250
Net income: 17765000
Capital expenditures: 3035000
Operating cash flow: 106218750
Depreciation & amortization: 10666250
Net tangible assets: 144932500
Owner earnings: 25396250
Return on net tangible assets (%): 17.52281234367723
Buffett classification: The Gruesome
Stock price: 0.008624999999999999
P/E ratio: 0.12325187047565436
Shares outstanding: 253863128
Book value: 183188750
P/B ratio: 0.011952532450819167
Market cap (USD): 2189569.479
Debt to equity: 0.12329496216334246
Effective tax rate (%): 19.222462203023756
COGS to revenue (%): 0
SG&A to revenue (%): 5.43823247970137
Free cash flow (dilution-adjusted): 86283750
Buyback yield (%): 13.929679004262374
Retained earnings: 183405000
Receivables turnover: 114.10702702702703
Capitalized R&D asset: 0
FCF margin (%): 65.39806156382343
Revenue growth (%): -23.957716243032657
Rule of 40 score: 41.440345320790776
Financial ratios for CABP.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 144932500
Buffett classification: The Gruesome
Stock price: 0.008624999999999999
Shares outstanding: 253863128
Book value: 183188750
P/B ratio: 0.011952532450819167
Market cap (USD): 2189569.479
Debt to equity: 0.12329496216334246
Buyback yield (%): 0
Retained earnings: 183405000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CABP.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 163354794.52054796
Buffett classification: The Gruesome
Stock price: 0.006301369863013699
Shares outstanding: 253863128
Book value: 204738356.16438365
P/B ratio: 0.007813315951531856
Market cap (USD): 1599685.464109589
Debt to equity: 0.12374631169752234
Buyback yield (%): 0
Retained earnings: 205106849.31506848
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCEC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.7
Shares outstanding: 60113445
Market cap (USD): 823554196.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCEC — annual report dated 2022-12-31
Total revenue: 199204255.31914896
Gross profit: 103425531.91489363
Operating income: 92062765.95744681
Net income: 133426595.74468085
Capital expenditures: 13465957.446808511
Operating cash flow: 183582978.72340426
Depreciation & amortization: 50547872.340425536
Net tangible assets: 644793617.0212766
Owner earnings: 170508510.63829786
Return on net tangible assets (%): 26.44388935268748
Capex to operating income (%): 14.626931210205804
Buffett classification: The Great
Stock price: 12.08
P/E ratio: 5.442471282034109
Shares outstanding: 60113445
Book value: 679176595.7446809
P/B ratio: 1.0691923428306491
Market cap (USD): 726170415.6
Debt to equity: 2.0191502225786544
Current ratio: 1.4026227019733513
Quick ratio: 1.345134086692528
Interest coverage ratio: 1.896495803291622
COGS to revenue (%): 48.08066135475188
SG&A to revenue (%): 5.70407792707154
Free cash flow (dilution-adjusted): 30847872.340425532
Buyback yield (%): 0.8659534645383075
Inventory turnover: 13.206982543640898
Receivables turnover: 32.6336702683862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.607589032810417
FCF margin (%): 15.485548885993206
Rule of 40 score: 15.485548885993206
Financial ratios for CCEC — annual report dated 2023-12-31
Total revenue: 243551111.1111111
Gross profit: 128805555.55555555
Operating income: 113866666.66666666
Net income: 52453333.33333333
Capital expenditures: 349505555.5555555
Operating cash flow: 209680000
Depreciation & amortization: 52843333.33333333
Net tangible assets: -82187777.77777778
Owner earnings: -244208888.88888887
Capex to operating income (%): 306.9428181108509
Buffett classification: The Gruesome
Stock price: 13.14
P/E ratio: 15.05892222864769
Shares outstanding: 60113445
Book value: 1305481111.1111112
P/B ratio: 0.60505713991351
Market cap (USD): 789890667.3000001
Debt to equity: 1.4287223186343392
Current ratio: 1.2260316424726798
Quick ratio: 1.2096993421410318
Interest coverage ratio: 1.215225898256848
COGS to revenue (%): 47.11354221792369
SG&A to revenue (%): 6.133779813500246
Free cash flow (dilution-adjusted): -168232222.2222222
Buyback yield (%): 0.5784204166516158
Retained earnings: 0
Inventory turnover: 34.37782956058589
Receivables turnover: 62.53808844507846
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4664143752014716
FCF margin (%): -69.07470939250716
Revenue growth (%): 22.26200224534019
Rule of 40 score: -46.81270714716697
Financial ratios for CCEC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.87
Shares outstanding: 60113445
Market cap (USD): 1074227262.15
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCEC — annual report dated 2024-12-31
Total revenue: 353696875
Gross profit: 202468750
Operating income: 185091666.6666667
Net income: 201702083.33333334
Capital expenditures: 1251246875
Operating cash flow: 249840625
Depreciation & amortization: 97402083.33333334
Net tangible assets: 1293119791.6666667
Owner earnings: -952142708.3333333
Return on net tangible assets (%): -73.6314388248704
Capex to operating income (%): 676.0146999234613
Buffett classification: The Gruesome
Stock price: 17.58
P/E ratio: 5.239382487455714
Shares outstanding: 60113445
Book value: 1398926041.6666665
P/B ratio: 0.7554326187544165
Market cap (USD): 1056794363.0999999
Debt to equity: 1.7834238913928768
Current ratio: 1.6655358924970531
Quick ratio: 1.6473545223437416
Interest coverage ratio: 1.4129134860050891
COGS to revenue (%): 42.75642101729058
SG&A to revenue (%): 4.912987521683174
Free cash flow (dilution-adjusted): -1008612500
Buyback yield (%): 0
Retained earnings: 106890625
Inventory turnover: 32.793991416309005
Receivables turnover: 70.44585062240662
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.5921438283182034
FCF margin (%): -285.1629661698312
Revenue growth (%): 45.224907160714615
Rule of 40 score: -239.93805900911656
Financial ratios for CCEC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.58
Shares outstanding: 60113445
Market cap (USD): 1056794363.0999999
Buyback yield (%): 0
Retained earnings: 106890625
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCEC — quarterly report dated 2025-03-31
Total revenue: 110909782.60869564
Gross profit: 68390217.39130434
Operating income: 63902173.91304348
Net income: 87735869.56521739
Capital expenditures: 55464130.43478261
Operating cash flow: 62086956.521739125
Depreciation & amortization: 29533695.65217391
Net tangible assets: 1537925000
Owner earnings: 61805434.78260869
Return on net tangible assets (%): 4.018754801606625
Capex to operating income (%): 86.7953733628168
Buffett classification: The Gruesome
Stock price: 18.57
P/E ratio: 3.1808731114820916
Shares outstanding: 60113445
Book value: 1537924999.9999995
P/B ratio: 0.7258524789245252
Market cap (USD): 1116306673.65
Debt to equity: 1.8072247261449825
Current ratio: 1.8296455742533706
Quick ratio: 1.8099329841654395
Interest coverage ratio: 2.117109006446037
COGS to revenue (%): 38.33707380656037
SG&A to revenue (%): 4.046571341768182
Free cash flow (dilution-adjusted): 4909782.608695652
Buyback yield (%): 0
Inventory turnover: 8.646772767462423
Receivables turnover: 18.67783269265971
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5002692267450615
FCF margin (%): 4.426825563276067
Rule of 40 score: 4.426825563276067
Financial ratios for CCEC — quarterly report dated 2025-06-30
Total revenue: 122540000
Gross profit: 71130588.23529412
Operating income: 66524705.88235294
Net income: 36684705.88235294
Capital expenditures: 93536470.5882353
Operating cash flow: 69964705.88235295
Depreciation & amortization: 34851764.705882356
Net tangible assets: 1593630588.235294
Owner earnings: -22000000.000000015
Return on net tangible assets (%): -1.3804955905346736
Capex to operating income (%): 140.60410992820007
Buffett classification: The Gruesome
Stock price: 22.73
P/E ratio: 10.981934458467276
Shares outstanding: 60113445
Book value: 1692768235.294118
P/B ratio: 0.8071858724431891
Market cap (USD): 1366378604.8500001
Debt to equity: 1.769920207276212
Current ratio: 1.6597264409712633
Quick ratio: 1.6383765026417039
Interest coverage ratio: 1.9580317878042868
COGS to revenue (%): 41.95316775314663
SG&A to revenue (%): 3.758676638600601
Free cash flow (dilution-adjusted): -25705882.352941178
Buyback yield (%): 0
Inventory turnover: 9.419702522095278
Receivables turnover: 14.380643379814995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.439469036370866
FCF margin (%): -20.977543947234516
Revenue growth (%): 10.486196183737283
Rule of 40 score: -10.491347763497233
Financial ratios for CCEC — quarterly report dated 2025-09-30
Total revenue: 117065882.35294119
Gross profit: 63062352.941176474
Operating income: 58831764.705882356
Net income: 27954117.647058826
Capital expenditures: 58487058.823529415
Operating cash flow: 78261176.47058824
Depreciation & amortization: 30891764.705882356
Net tangible assets: 1632421176.4705882
Owner earnings: 358823.5294117704
Return on net tangible assets (%): 0.021981063133937814
Capex to operating income (%): 99.414082028516
Buffett classification: The Gruesome
Stock price: 22.03
P/E ratio: 8.691070455692874
Shares outstanding: 60113445
Book value: 1721090588.2352943
P/B ratio: 0.7694535095377281
Market cap (USD): 1324299193.3500001
Debt to equity: 1.65702936646873
Current ratio: 1.438067496529595
Quick ratio: 1.4244101937249878
Interest coverage ratio: 1.8608640643024599
COGS to revenue (%): 46.130886579703734
SG&A to revenue (%): 3.6138524310091853
Free cash flow (dilution-adjusted): 17877647.05882353
Buyback yield (%): 0
Inventory turnover: 10.926684122827899
Receivables turnover: 15.458443374242659
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3058990169523748
FCF margin (%): 15.271440918135589
Revenue growth (%): -4.467208786566684
Rule of 40 score: 10.804232131568906
Financial ratios for CCEC — annual report dated 2025-12-31
Total revenue: 462007058.8235294
Gross profit: 270038823.5294118
Operating income: 251688235.29411766
Net income: 200892941.1764706
Capital expenditures: 370989411.7647059
Operating cash flow: 284778823.5294118
Depreciation & amortization: 129175294.11764707
Net tangible assets: 1685611764.7058823
Owner earnings: -40921176.47058821
Return on net tangible assets (%): -2.4276750629898713
Capex to operating income (%): 147.4003786196742
Buffett classification: The Gruesome
Stock price: 20.57
P/E ratio: 6.155186719894704
Shares outstanding: 60113445
Book value: 1763961176.4705887
P/B ratio: 0.7009981739644128
Market cap (USD): 1236533563.65
Debt to equity: 1.570220633107171
Current ratio: 1.3763229991858466
Quick ratio: 1.3634580840257944
Interest coverage ratio: 2.0744608641688
COGS to revenue (%): 41.550931230997236
SG&A to revenue (%): 3.971928109068871
Free cash flow (dilution-adjusted): -93734117.64705883
Buyback yield (%): 0
Retained earnings: 279141176.47058827
Inventory turnover: 40.9776494224008
Receivables turnover: 46.54569159653906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.651298740751112
FCF margin (%): -20.28846006936487
Revenue growth (%): 30.62231856686023
Rule of 40 score: 10.33385849749536
Financial ratios for CCEC — quarterly report dated 2025-12-31
Total revenue: 102071764.70588236
Gross profit: 61532941.17647059
Operating income: 56880000
Net income: 42962352.941176474
Capital expenditures: 158675294.11764705
Operating cash flow: 70287058.8235294
Depreciation & amortization: 28955294.11764706
Net tangible assets: 1685611764.7058823
Owner earnings: -86757647.05882353
Return on net tangible assets (%): -5.146953104824919
Capex to operating income (%): 278.9650037230082
Buffett classification: The Gruesome
Stock price: 20.57
P/E ratio: 6.330256286476971
Shares outstanding: 60113445
Book value: 1763961176.4705887
P/B ratio: 0.7009981739644128
Market cap (USD): 1236533563.65
Debt to equity: 1.570220633107171
Current ratio: 1.3763229991858466
Quick ratio: 1.3634580840257944
Interest coverage ratio: 2.4472565296618747
COGS to revenue (%): 39.716001429213584
SG&A to revenue (%): 4.558499786770554
Free cash flow (dilution-adjusted): -90284705.88235293
Buyback yield (%): 0
Retained earnings: 279141176.47058827
Inventory turnover: 8.653440482169763
Receivables turnover: 10.283394571530165
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2771589105000805
FCF margin (%): -88.45218473738198
Revenue growth (%): -12.808272867967766
Rule of 40 score: -101.26045760534976
Financial ratios for CMC — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.48
Shares outstanding: 110624335
Market cap (USD): 3371829730.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMC — annual report dated 2022-08-31
Total revenue: 8913481000
Gross profit: 1856396000
Operating income: 1311412000
Net income: 1217262000
Capital expenditures: 315148000
Operating cash flow: 700309000
Depreciation & amortization: 175024000
Net tangible assets: 2779039000
Owner earnings: 1077138000
Return on net tangible assets (%): 38.75936969578333
Capex to operating income (%): 24.031196908370518
Buffett classification: The Great
Stock price: 38.43
P/E ratio: 3.492504648999147
Shares outstanding: 110624335
Book value: 3286429000
P/B ratio: 1.293590457621327
Market cap (USD): 4251293194.05
Debt to equity: 0.4570447132738909
Current ratio: 2.536109778501931
Quick ratio: 1.6741295237168816
Effective tax rate (%): 19.66046858819639
Interest coverage ratio: 25.861523595416987
COGS to revenue (%): 79.17316478264776
SG&A to revenue (%): 6.114154503723068
Free cash flow (dilution-adjusted): 203343000
Buyback yield (%): 3.8077825407704893
Retained earnings: 3312438000
Inventory turnover: 6.033264198560993
Receivables turnover: 6.559301703501417
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.872976451012697
FCF margin (%): 2.2812972844167168
Rule of 40 score: 2.2812972844167168
Financial ratios for CMC — annual report dated 2023-08-31
Total revenue: 8799533000
Gross profit: 1811915000
Operating income: 1165874000
Net income: 859760000
Capital expenditures: 1006000
Operating cash flow: 1344103000
Depreciation & amortization: 218830000
Net tangible assets: 3475891000
Owner earnings: 1077584000
Return on net tangible assets (%): 31.001662595288515
Capex to operating income (%): 0.08628719741584424
Buffett classification: The Great
Stock price: 54.1
P/E ratio: 6.960985069670606
Shares outstanding: 110624335
Book value: 4121114000
P/B ratio: 1.45222299686444
Market cap (USD): 5984776523.5
Debt to equity: 0.28021476717217725
Current ratio: 3.7265649260294365
Quick ratio: 2.4991561121422663
Effective tax rate (%): 23.370295204760925
Interest coverage ratio: 29.054601639793656
COGS to revenue (%): 79.4089640893443
SG&A to revenue (%): 7.341764614099406
Free cash flow (dilution-adjusted): 676909000
Buyback yield (%): 1.6943991074991056
Retained earnings: 4097262000
Inventory turnover: 6.747527477302619
Receivables turnover: 7.095155928357698
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.117300332333688
FCF margin (%): 7.692555957230912
Revenue growth (%): -1.2783782228289935
Rule of 40 score: 6.414177734401918
Financial ratios for CMC — annual report dated 2024-08-31
Total revenue: 7925972000
Gross profit: 1358685000
Operating income: 690272000
Net income: 485491000
Capital expenditures: 756000
Operating cash flow: 899708000
Depreciation & amortization: 280367000
Net tangible assets: 3679277000
Owner earnings: 765102000
Return on net tangible assets (%): 20.794900737291595
Capex to operating income (%): 0.10952204348430764
Buffett classification: The Great
Stock price: 52.21
P/E ratio: 11.896608856497854
Shares outstanding: 110624335
Book value: 4300024000
P/B ratio: 1.343177742810273
Market cap (USD): 5775696530.35
Debt to equity: 0.276654502393475
Current ratio: 3.944143259268132
Quick ratio: 2.7801557165957957
Effective tax rate (%): 23.62542887751683
Interest coverage ratio: 14.412795189276094
COGS to revenue (%): 82.8578122658016
SG&A to revenue (%): 8.433199107945374
Free cash flow (dilution-adjusted): 530371000
Buyback yield (%): 3.167271670849274
Retained earnings: 4503885000
Inventory turnover: 6.7581715555875705
Receivables turnover: 6.838948492854715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.537243341079183
FCF margin (%): 6.691557830383453
Revenue growth (%): -9.92735637220748
Rule of 40 score: -3.2357985418240274